BRUKER CORP (BRKR) Fundamental Analysis & Valuation

NASDAQ:BRKR • US1167941087

Current stock price

34.29 USD
-1.97 (-5.43%)
At close:
33.81 USD
-0.48 (-1.4%)
After Hours:

This BRKR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BRKR Profitability Analysis

1.1 Basic Checks

  • In the past year BRKR was profitable.
  • BRKR had a positive operating cash flow in the past year.
  • BRKR had positive earnings in 4 of the past 5 years.
  • In the past 5 years BRKR always reported a positive cash flow from operatings.
BRKR Yearly Net Income VS EBIT VS OCF VS FCFBRKR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • With a decent Return On Assets value of -0.36%, BRKR is doing good in the industry, outperforming 64.91% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -0.92%, BRKR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Return On Invested Capital of BRKR (4.32%) is better than 71.93% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BRKR is below the industry average of 11.01%.
Industry RankSector Rank
ROA -0.36%
ROE -0.92%
ROIC 4.32%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.91%
ROIC(5y)9.93%
BRKR Yearly ROA, ROE, ROICBRKR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • BRKR has a better Operating Margin (7.90%) than 64.91% of its industry peers.
  • In the last couple of years the Operating Margin of BRKR has declined.
  • The Gross Margin of BRKR (47.13%) is comparable to the rest of the industry.
  • BRKR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.9%
PM (TTM) N/A
GM 47.13%
OM growth 3Y-24.07%
OM growth 5Y-9.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.99%
GM growth 5Y-0.06%
BRKR Yearly Profit, Operating, Gross MarginsBRKR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

3

2. BRKR Health Analysis

2.1 Basic Checks

  • BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BRKR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BRKR has about the same amount of shares outstanding.
  • BRKR has a better debt/assets ratio than last year.
BRKR Yearly Shares OutstandingBRKR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BRKR Yearly Total Debt VS Total AssetsBRKR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • BRKR has an Altman-Z score of 2.28. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BRKR has a better Altman-Z score (2.28) than 61.40% of its industry peers.
  • The Debt to FCF ratio of BRKR is 131.63, which is on the high side as it means it would take BRKR, 131.63 years of fcf income to pay off all of its debts.
  • BRKR's Debt to FCF ratio of 131.63 is in line compared to the rest of the industry. BRKR outperforms 50.88% of its industry peers.
  • BRKR has a Debt/Equity ratio of 0.75. This is a neutral value indicating BRKR is somewhat dependend on debt financing.
  • BRKR has a worse Debt to Equity ratio (0.75) than 70.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 131.63
Altman-Z 2.28
ROIC/WACC0.42
WACC10.2%
BRKR Yearly LT Debt VS Equity VS FCFBRKR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • BRKR has a Current Ratio of 1.73. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
  • BRKR has a worse Current ratio (1.73) than 73.68% of its industry peers.
  • A Quick Ratio of 0.86 indicates that BRKR may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.86, BRKR is not doing good in the industry: 85.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 0.86
BRKR Yearly Current Assets VS Current LiabilitesBRKR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. BRKR Growth Analysis

3.1 Past

  • BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.07%.
  • Measured over the past 5 years, BRKR shows a small growth in Earnings Per Share. The EPS has been growing by 6.27% on average per year.
  • BRKR shows a small growth in Revenue. In the last year, the Revenue has grown by 2.08%.
  • Measured over the past years, BRKR shows a quite strong growth in Revenue. The Revenue has been growing by 11.57% on average per year.
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%

3.2 Future

  • Based on estimates for the next years, BRKR will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.62% on average per year.
  • The Revenue is expected to grow by 3.77% on average over the next years.
EPS Next Y18.09%
EPS Next 2Y16.05%
EPS Next 3Y16.03%
EPS Next 5Y12.62%
Revenue Next Year4.7%
Revenue Next 2Y4.25%
Revenue Next 3Y4.46%
Revenue Next 5Y3.77%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRKR Yearly Revenue VS EstimatesBRKR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
BRKR Yearly EPS VS EstimatesBRKR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. BRKR Valuation Analysis

4.1 Price/Earnings Ratio

  • BRKR is valuated rather expensively with a Price/Earnings ratio of 18.74.
  • 85.96% of the companies in the same industry are more expensive than BRKR, based on the Price/Earnings ratio.
  • BRKR is valuated rather cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 15.87, BRKR is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 85.96% of the companies listed in the same industry.
  • BRKR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.74
Fwd PE 15.87
BRKR Price Earnings VS Forward Price EarningsBRKR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 84.21% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as BRKR.
Industry RankSector Rank
P/FCF 367.58
EV/EBITDA 14.41
BRKR Per share dataBRKR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • BRKR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as BRKR's earnings are expected to grow with 16.03% in the coming years.
PEG (NY)1.04
PEG (5Y)2.99
EPS Next 2Y16.05%
EPS Next 3Y16.03%

5

5. BRKR Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.55%, BRKR is not a good candidate for dividend investing.
  • In the last 3 months the price of BRKR has falen by -22.58%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.11, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.47% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, BRKR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

  • The dividend of BRKR is nicely growing with an annual growth rate of 6.15%!
  • BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)6.15%
Div Incr Years0
Div Non Decr Years9
BRKR Yearly Dividends per shareBRKR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • BRKR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of BRKR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-146.22%
EPS Next 2Y16.05%
EPS Next 3Y16.03%
BRKR Yearly Income VS Free CF VS DividendBRKR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

BRKR Fundamentals: All Metrics, Ratios and Statistics

BRUKER CORP

NASDAQ:BRKR (4/29/2026, 8:00:01 PM)

After market: 33.81 -0.48 (-1.4%)

34.29

-1.97 (-5.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength17.39
Industry Growth53.42
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners92.3%
Inst Owner Change-1.32%
Ins Owners26.93%
Ins Owner Change0.1%
Market Cap5.22B
Revenue(TTM)3.44B
Net Income(TTM)-22.50M
Analysts79.09
Price Target48.87 (42.52%)
Short Float %11.5%
Short Ratio6.06
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.22
Dividend Growth(5Y)6.15%
DP-146.22%
Div Incr Years0
Div Non Decr Years9
Ex-Date03-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.4%
Min EPS beat(2)-10.9%
Max EPS beat(2)31.69%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)1.39%
EPS beat(12)8
Avg EPS beat(12)4.7%
EPS beat(16)11
Avg EPS beat(16)5.48%
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)-0.29%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)1
Avg Revenue beat(8)-1.04%
Revenue beat(12)5
Avg Revenue beat(12)0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.64%
PT rev (1m)-2.13%
PT rev (3m)-9.84%
EPS NQ rev (1m)0.92%
EPS NQ rev (3m)-42.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.92%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-1.05%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)3.16%
Valuation
Industry RankSector Rank
PE 18.74
Fwd PE 15.87
P/S 1.52
P/FCF 367.58
P/OCF 38.84
P/B 2.12
P/tB 567.35
EV/EBITDA 14.41
EPS(TTM)1.83
EY5.34%
EPS(NY)2.16
Fwd EY6.3%
FCF(TTM)0.09
FCFY0.27%
OCF(TTM)0.88
OCFY2.57%
SpS22.58
BVpS16.14
TBVpS0.06
PEG (NY)1.04
PEG (5Y)2.99
Graham Number25.7774 (-24.83%)
Profitability
Industry RankSector Rank
ROA -0.36%
ROE -0.92%
ROCE 5.47%
ROIC 4.32%
ROICexc 4.6%
ROICexgc 9.68%
OM 7.9%
PM (TTM) N/A
GM 47.13%
FCFM 0.41%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.91%
ROIC(5y)9.93%
ROICexc(3y)8.9%
ROICexc(5y)13.25%
ROICexgc(3y)16.34%
ROICexgc(5y)22.09%
ROCE(3y)10.01%
ROCE(5y)12.56%
ROICexgc growth 3Y-29.19%
ROICexgc growth 5Y-14.74%
ROICexc growth 3Y-36.05%
ROICexc growth 5Y-19.66%
OM growth 3Y-24.07%
OM growth 5Y-9.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.99%
GM growth 5Y-0.06%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 131.63
Debt/EBITDA 3.77
Cap/Depr 54.56%
Cap/Sales 3.5%
Interest Coverage 3.83
Cash Conversion 27.32%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 0.86
Altman-Z 2.28
F-Score4
WACC10.2%
ROIC/WACC0.42
Cap/Depr(3y)70.11%
Cap/Depr(5y)91.82%
Cap/Sales(3y)3.51%
Cap/Sales(5y)3.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
EPS Next Y18.09%
EPS Next 2Y16.05%
EPS Next 3Y16.03%
EPS Next 5Y12.62%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%
Revenue Next Year4.7%
Revenue Next 2Y4.25%
Revenue Next 3Y4.46%
Revenue Next 5Y3.77%
EBIT growth 1Y-29.82%
EBIT growth 3Y-15.92%
EBIT growth 5Y0.46%
EBIT Next Year53.17%
EBIT Next 3Y21.01%
EBIT Next 5Y17.15%
FCF growth 1Y-89.56%
FCF growth 3Y-53.93%
FCF growth 5Y-42.95%
OCF growth 1Y-46.52%
OCF growth 3Y-21.17%
OCF growth 5Y-16.56%

BRUKER CORP / BRKR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRUKER CORP?

ChartMill assigns a fundamental rating of 4 / 10 to BRKR.


What is the valuation status for BRKR stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUKER CORP (BRKR). This can be considered as Fairly Valued.


What is the profitability of BRKR stock?

BRUKER CORP (BRKR) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BRKR stock?

The Price/Earnings (PE) ratio for BRUKER CORP (BRKR) is 18.74 and the Price/Book (PB) ratio is 2.12.


Can you provide the dividend sustainability for BRKR stock?

The dividend rating of BRUKER CORP (BRKR) is 5 / 10 and the dividend payout ratio is -146.22%.